Forty-eight-hour small grants for bold experiments in neglected cancers
Fast grants for oncology would be a fund that decides within two days on small grants for quick, decisive experiments in cancers or questions that mainstream funders neglect, modelled on the pandemic-era Fast Grants.
Fast Grants during COVID-19 funded hundreds of projects with 48-hour decisions and a one-page application; several led to important results, and recipients reported that speed, not just money, changed what they attempted. A cancer version would target neglected cancers and unfashionable questions (cachexia, metastasis models, surgical technique, repurposed drugs) with awards of $10,000 to $500,000, pre-registration of the key experiment, and a public results record including failures.
- Funding follows fashion, not burden · Money goes to the cancers and questions that are easy or popular, not the ones that kill most or where a dollar would do most.
- The valley of death between lab and product · Most academic discoveries die before anyone tests them in people because nobody funds the middle step.
Pages like this
not linked directly; found by shared links- InstitutionWorldwide Cancer Research
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- IdeaA public-benefit phase 1 factory that takes academic discoveries into first-in-human trials
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- InstitutionCancer Prevention and Research Institute of Texas
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- IdeaA fast IND-enabling fund that pays for toxicology and manufacturing in eight weeks
Shares A phase 0 fund to test academic compounds in humans with microdoses and imaging, The valley of death between lab and product.
- PersonJudah Folkman
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- IdeaSet aside 3% of grant budgets to replicate findings before translation
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- IdeaA university cyclotron network with shared regulatory files for new tracers
Shares A phase 0 fund to test academic compounds in humans with microdoses and imaging, The valley of death between lab and product.